Surrozen (SRZN) Competitors $9.03 -1.33 (-12.84%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$9.38 +0.35 (+3.88%) As of 08/7/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRZN vs. TNXP, CAPR, CYRX, AURA, ABEO, NBTX, RCKT, ESPR, ARCT, and AMRNShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include Tonix Pharmaceuticals (TNXP), Capricor Therapeutics (CAPR), CryoPort (CYRX), Aura Biosciences (AURA), Abeona Therapeutics (ABEO), Nanobiotix (NBTX), Rocket Pharmaceuticals (RCKT), Esperion Therapeutics (ESPR), Arcturus Therapeutics (ARCT), and Amarin (AMRN). These companies are all part of the "pharmaceutical products" industry. Surrozen vs. Its Competitors Tonix Pharmaceuticals Capricor Therapeutics CryoPort Aura Biosciences Abeona Therapeutics Nanobiotix Rocket Pharmaceuticals Esperion Therapeutics Arcturus Therapeutics Amarin Surrozen (NASDAQ:SRZN) and Tonix Pharmaceuticals (NASDAQ:TNXP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment. Does the media favor SRZN or TNXP? In the previous week, Surrozen and Surrozen both had 2 articles in the media. Tonix Pharmaceuticals' average media sentiment score of 0.92 beat Surrozen's score of 0.00 indicating that Tonix Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surrozen 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tonix Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SRZN or TNXP more profitable? Surrozen has a net margin of 0.00% compared to Tonix Pharmaceuticals' net margin of -1,313.87%. Tonix Pharmaceuticals' return on equity of -120.96% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets SurrozenN/A -842.90% -71.32% Tonix Pharmaceuticals -1,313.87%-120.96%-101.28% Which has preferable earnings & valuation, SRZN or TNXP? Surrozen has higher revenue and earnings than Tonix Pharmaceuticals. Surrozen is trading at a lower price-to-earnings ratio than Tonix Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurrozen$11.64M6.64-$63.56M-$24.96-0.36Tonix Pharmaceuticals$10.04M34.38-$130.04M-$1.96 thousand-0.02 Do analysts recommend SRZN or TNXP? Surrozen presently has a consensus target price of $38.50, suggesting a potential upside of 326.36%. Tonix Pharmaceuticals has a consensus target price of $70.00, suggesting a potential upside of 49.19%. Given Surrozen's higher probable upside, equities analysts plainly believe Surrozen is more favorable than Tonix Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surrozen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Tonix Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, SRZN or TNXP? Surrozen has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Tonix Pharmaceuticals has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500. Do institutionals & insiders hold more shares of SRZN or TNXP? 66.6% of Surrozen shares are owned by institutional investors. Comparatively, 82.3% of Tonix Pharmaceuticals shares are owned by institutional investors. 45.2% of Surrozen shares are owned by company insiders. Comparatively, 0.0% of Tonix Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummarySurrozen beats Tonix Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRZN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$88.70M$2.51B$5.48B$9.56BDividend YieldN/A1.78%3.99%4.17%P/E Ratio-0.3619.6629.9325.14Price / Sales6.64425.10375.2276.13Price / CashN/A165.0335.9458.58Price / Book-1.384.198.105.59Net Income-$63.56M$31.61M$3.26B$265.48M7 Day Performance-17.91%0.95%0.68%1.22%1 Month Performance8.93%2.90%2.45%0.39%1 Year Performance27.18%4.11%27.72%23.47% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen1.8253 of 5 stars$9.03-12.8%$38.50+326.4%+25.4%$88.70M$11.64M-0.3680News CoveragePositive NewsUpcoming EarningsGap DownTNXPTonix Pharmaceuticals3.2459 of 5 stars$47.70+6.9%$70.00+46.8%+2.0%$350.93M$10.04M-0.0250Upcoming EarningsCAPRCapricor Therapeutics3.5897 of 5 stars$7.67-0.1%$22.56+194.1%+126.7%$350.37M$22.27M-5.40101Trending NewsCYRXCryoPort3.657 of 5 stars$6.74-5.9%$10.63+57.6%+5.5%$337.94M$228.38M-2.881,186Trending NewsEarnings ReportAnalyst UpgradeAnalyst RevisionAURAAura Biosciences1.969 of 5 stars$6.63+0.3%$22.00+231.8%-20.0%$333.29MN/A-3.4950News CoverageUpcoming EarningsABEOAbeona Therapeutics3.8846 of 5 stars$6.47+0.8%$19.25+197.5%+41.9%$331.01M$3.50M-5.0990Upcoming EarningsNBTXNanobiotix0.8266 of 5 stars$6.93+1.8%$8.00+15.5%+53.6%$326.38M$39.18M0.00100Gap UpRCKTRocket Pharmaceuticals4.8419 of 5 stars$3.04-1.0%$17.87+487.7%-83.7%$324.64MN/A-1.16240Trending NewsEarnings ReportESPREsperion Therapeutics4.069 of 5 stars$1.62+8.7%$7.00+332.1%-7.7%$321.08M$332.31M-2.02200Earnings ReportAnalyst RevisionGap UpARCTArcturus Therapeutics2.8356 of 5 stars$11.83-3.0%$54.00+356.5%-36.0%$320.84M$131.27M-4.68180News CoveragePositive NewsUpcoming EarningsAMRNAmarin0.5585 of 5 stars$15.13-1.6%$12.00-20.7%+15.1%$313.34M$228.61M-4.12360 Related Companies and Tools Related Companies TNXP Competitors CAPR Competitors CYRX Competitors AURA Competitors ABEO Competitors NBTX Competitors RCKT Competitors ESPR Competitors ARCT Competitors AMRN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRZN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRZN Stock Alerts